26-Year-Old Beats Stage II Hodgkin's Lymphoma

In the spring of 2024, Conor Mulvanerton, then in his early twenties, began experiencing persistent fatigue and drenching night sweats. He initially attributed these symptoms to his demanding job as a Starbucks barista and the summer heat. However, by November 2024, these warning signs escalated, leading to his diagnosis of stage II Hodgkin's lymphoma.

Despite reassurances that his cancer was highly treatable, Mulvanerton's initial chemotherapy rounds were followed by a PET scan that revealed the fight was far from over. The demanding treatment regimen, including 12 rounds of chemotherapy and an autologous stem cell transplant in September 2025, significantly impacted his health and career aspirations. He found crucial support in friends, family, and music, which motivated him through his difficult treatment.

By December 2025, Mulvanerton received the life-changing news that his post-transplant PET scan showed no signs of cancer. He is now focused on rebuilding his strength through running and healthier lifestyle choices, determined to remain cancer-free and embrace life following his remission.